維力醫療(603309.SH):目前公司所有產品的產能利用率均接近飽和狀態
格隆匯8月15日丨維力醫療(603309.SH)近日在接待機構投資者調研時表示,目前公司主要產品的產能全部集中在國內,在5個城市有生產基地。廣州本部有2個廠區,主要生產麻醉、泌尿外科、護理和呼吸產品,海口廠區主要生產導尿產品,張家港廠區主要生產血透產品,蘇州廠區主要生產鎮痛泵產品,江西省吉安廠區主要生產泌尿外科中的男科產品。公司一直在持續進行產能優化和生產自動化升級,目前公司所有產品的產能利用率均接近飽和狀態。
為應對國內醫療耗材集採和海外大客户業務不斷增長的產能需求,以及日益緊張的海外地緣政治風險,公司正在積極籌建國內肇慶自動化生產基地以及海外墨西哥工廠。待上述2個項目建成後,公司產能和自動化生產水平都將得到大幅提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.